Puma Exploration and Votorantim Metals Canada amend the terms of the Murray Brook Property Agreement
Momentum Public Relations
Press Release: January 25, 2017
Puma Exploration inc. (the “Company” or “Puma”) (TSX VENTURE:PUM)(SSE:PUMA) is pleased to announce that by mutual agreement, Votorantim Metals Canada Inc. (“Votorantim”) and Puma have agreed to modify the terms of the amended and restated Asset Purchase Agreement signed October 5th, 2016 to facilitate and accelerate the final closing of the acquisition of the Murray Brook Property which include the transfer of the mining claims to Puma.
To satisfy the new requirements as set in the amended agreement signed November 27th 2017, Puma will proceed with the $2M cash consideration on February 28th, 2018 as previously agreed. The date at which the Environmental Bond will be assumed by Puma has been postponed to December 31st, 2018, the date of the final cash consideration payment. Once the final cash consideration payment is done and that Puma has assumed the Environmental bond, the mining claims will be transferred to Puma.
“We are very pleased with this new mutual agreement that provides Puma with more flexibility in achieving our shared objective in finalizing the acquisition of the Murray Brook Property. The delay of the release of the Environmental Bond will let us focus on exploring and developing the Murray Brook Deposit” notes Marcel Robillard, President of Puma.
Except as specifically modified pursuant to the present release, no other changes or modifications to the Asset Purchase Agreement are intended or implied or have otherwise been agreed between the Parties. The present modifications have to be reviewed by the usual regulatory agencies.
Current Exploration Program
The second phase of the 2017 exploration program has begun on prospective new areas on both sides of the Murray Brook Deposit and initially consists of trenching. Puma’s geologists have defined several new high priority targets based on their stratigraphic location, their proximity to the Deposit and along the best geophysical anomalies.
So far, 11 trenches have been completed for a total of 803 meters. Along the Western side of the Murray Brook Deposit, altered black shales units were discovered and contain disseminated sulphides and also small veinlets of sulphide. The mineralized rocks, visually similar to the Murray Brook Deposit footwall sediments, were found over a strong chargeability and gravity anomalies. This trenching program was also aimed at defining several high priority targets that will be tested in the coming drilling program.
Corporate Matter
An insider of the Company has participated in the recent September 15th, 2017 flow through private placement for an amount of $1,000.00 (representing 1% of the total placement). This insider subscribed to the units on the same terms as the other investors. The participation of an insider is exempt of the standard regulatory acceptance as well as of the approval of the shareholders of the Company according to sections 5.5 (a) and 5.7 (a) of the Regulation 61-101 « Regulation 61-101 » concerning the protection of minor shareholders in a special transaction. This exemption is based on the fact that the market value of the placement or the amount paid by each of the total insiders does not represent more than 25% of the market value of the Company.
Qualified Persons and QC/AC
The content of this press release was prepared by Marcel Robillard, P.Geo., President and Dominique Gagné, P.Geo., Vice President Exploration of Puma Exploration, qualified persons as defined by NI 43-101, who supervised the preparation and technical information that forms the basis for this news release. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Mr. Robillard and Mr. Gagné are not independent of the Company, as both are officers and shareholders thereof. The samples were prepared, sent, processed at ALS Val D’Or, Québec and ALS Sudbury, Ontario. All samples were assayed by ME-ICP41 method and gold was assayed by AU-AA26 method. QA/QC are monitored by the analysis of blanks, reference material and replicate samples at a frequency of one (1) of each per 30 samples.
About the Murray Brook Project
The Murray Brook Project consists of three (3) distinct contiguous areas that cover more than 18 kilometers of the favorable rocks that host the operating Caribou Mine (Trevali Mining Corp.), the Murray Brook Deposit and the past operating Restigouche Mine (Trevali Mining Corp.). From east to west, the project comprises the Murray Brook East Property (4925), the Murray Brook Mining Lease (# 252) and the Murray Brook West Property (7846) (refer to website).
The Murray Brook East and Murray Brook West Properties have been subject to various degrees of exploration and share the same potential of increasing the mineral resources defined at the Murray Brook Deposit. The Company has defined several future priority targets on these properties.
The Murray Brook deposit has a currently defined measured and indicated mineral resources of 5.28 million tonnes averaging 5.24% zinc, 1.80% lead, 0.46% copper, 68.9 g/t silver and 0.65 g/t gold. The core of the mineral resource occurs in the West Zone which is 200 meters wide, extending from surface to 300 meters vertical and the true thickness of the massive sulphide body varies from 75 meters to 100 meters. The East Zone (Copper-Gold) is 100 meters wide, also extending from surface to 300 vertical meters and is mainly mineralized with gold and copper. On February 20th 2017, a NI 43-101 report was accepted and filed on SEDAR.
About Puma Exploration Inc.
Puma Exploration is a Canadian mineral exploration company with advanced precious and base metals projects in Canada. The Company’s major assets consist of an option to acquire 100% beneficial interest in the Murray Brook Property, the Turgeon Zinc-Copper Project and the Nicholas-Denys Project located in New Brunswick as well as an equity interest in BWR Resources, Manitoba. Puma’s objective for the coming year is to focus its exploration efforts in New Brunswick.
You can visit us on Facebook and Twitter.
Learn more by consulting www.pumaexploration.com for further information on Puma Exploration Inc.
Forward-Looking Statements: This press release may contain forward-looking statements. Such forward-looking statements involve a number of known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Puma Exploration Inc. to be materially different from actual future results and achievements expressed or implied by such forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements which speak only as of the date the statements were made, except as required by law. Puma Exploration undertakes no obligation to publicly update or revise any forward-looking statements. These risks and uncertainties are described in the quarterly and annual reports and in the documents submitted to the securities administration.
Puma Exploration Inc.
Marcel Robillard
President
(418) 724-0901
president@explorationpuma.com
www.pumaexploration.com
- Published in Puma Exploration
Is Big Ganja The Next Big Pharma?
Is Big Ganja The Next Big Pharma?
2016 brought the demise of Bowie, the rise of the alt-right and the surprise election of a Cheeto as President of the United States.
The 420 front was one of few sectors growing by leaps and bounds. Last year may have been the biggest ever for marijuana reform, with three additional states giving the nod to medical pot and four to recreational use.
Cannabis research firm The ArcView Group predicts a staggering $22 billion in legal marijuana sales by 2020. Unwilling to let grass grow under their feet, tech giants are prepared to spend big for a place in the race to become the Google of cannabis.
Marijuana and tech conspired in a big way in 2016. Microsoft and Oracle Corporation backed seed-to-sale software helping medical cannabis companies transact in compliance with regulations.
However, the year’s fresh crop of cannabis hardware is the real talking point; 2016 introduced marijuana tech products of a novel strain. These innovations expertly blur boundaries between medical technology and consumer goods. One such gadget is LEAF, an automated home growing system managed via smartphone app.
“I’ve been using [medical cannabis] since I got out of the [Israeli] military in 2010,” says LEAF CEO Yoni Ofir. His Colorado-based company offers plug ‘n plant technology that automates every conceivable factor in the growing process, such as nutrition, temperature and humidity regulation. “You can use data and sensors to make everything accurate and increase the chance of a great crop,” says Ofir.
With LEAF on their side, medical marijuana patients and recreational users alike can grow their own cannabis with minimal physical input. “It’s basically a medical-grade lab,” says Ofir. Besides helping stoners get the best from their bud, LEAF could be a lifeline for patients with chronic illnesses and disabilities. Conserving time, money and effort makes it much simpler to maintain treatment plans.
From an aesthetic perspective, LEAF’s sleek device would look perfectly at home in an Apple store. “Design leads everything that we do at our company,” says Ofir. “It should be important for any upcoming marijuana tech company.”
The past year’s other marijuana tech innovations mirror LEAF’s preoccupation with both automation and aesthetics. Tel Aviv-based Syqe (pronounced ‘Psyche’) Medical’s pocket-sized cannabis inhaler delivers precision dosing through preloaded cartridges. The device’s current incarnation features chic white casing reminiscent of a Fujifilm Instax camera.
Photo courtesy of Syqe Medical
LEAF’s hefty price tag makes it near inaccessible to those who could benefit most from automated growing. The LEAF system itself will set consumers back a cool $2,990. Filters and nutrient packs required for a single grow cost $39 a pop. Once launched in the U.S., Syqe’s inhaler could also come at a similarly high buying cost with comparable long-term maintenance expenses.
Even though it’s usually cheaper than recreational pot, medical marijuana still isn’t cheap, and can cost around $40 for an eighth of an ounce, according to a user generated data bank called PriceOfWeed.com that’s on the low end of the spectrum. Investing in LEAF would certainly cut costs in the long run, it’s simply a case of spending money now to save money in the future. Investment buys are out of reach for many patients prescribed medicinal Mary Jane, whether we’re talking about a medical device or a Rolex.
If cannabis tech becomes user experience-focused at the expense of accessibility, essential innovations could be limited to the recreational market. Marijuana tech companies are ultimately profit-driven businesses, but there’s plenty that can be done on both company practice and federal policy levels.
“With technology, the more units being sold, the cheaper the price,” says Ofir. “Medical users have a lot to gain, because it just happens to be the same plant that the recreational users want.” However, companies have more socially responsible options available than developing a device and letting the free market decide its accessibility.
Price breaks from marijuana tech companies could offer a practical solution to increased accessibility. Several New Jersey dispensaries offer discounts to low-income patients, military veterans, senior citizens and minors. If cannabis companies applied this approach to their retail policy, medical users could have increased access to vital treatment tools without compromising on profitability.
In contrast with the inaccessibility of some medical marijuana hardware, accessible advances can and do exist in the realm of software. Releaf, a free app for Android and iOS helps patients manage cannabis dosing and gather treatment data for doctors. This sleek, intuitive app holds a five-star average rating across platforms.
Although currently unmonetized, Releaf offers ample opportunity for future monetization models such as in-app purchases and sponsorships. The only limit is developer Automata Studios’ creativity.
Photo courtesy of LEAF
A major shift in federal policy is also key to ensure widespread marijuana tech accessibility for medical users. The Controlled Substances Act classifies cannabis as a Schedule I drug without medicinal value, although policy at state levels often differs. Health insurance companies, whether funded privately or via social welfare programs, steer clear of this murky territory to the detriment of patients.
Medical marijuana patients are almost always forced to pay out of pocket for prescribed expenses. Marijuana Policy Project state policies director Karen O’Keefe blames bureaucratic obstacles for this lack of assistance. “In our experience, the vast majority of health insurance companies have not been willing to cover medical marijuana,” says O’Keefe. “Most or all medical marijuana laws explicitly say [insurance companies] are not required to cover the costs of medical cannabis.”
Without policy reform to facilitate coverage, technological bells and whistles like LEAF will remain inaccessible to those who could benefit from them most. “The passage of the CARERS Act, which would change federal law to formally recognize state medical marijuana programs, or the outright de-scheduling of marijuana are the most important,” says O’Keefe.
It’s too soon to tell what the incoming Trump administration could mean for medical marijuana policy. However, cannabis tech companies certainly hold sway in ensuring more immediate access to innovations for medical users. Rather than relying on trickle-down of treatment tools via recreational consumers, targeted price breaks and placing pressure on insurance providers could make the world of difference for patients without tarnishing turnover.
- Published in Blog, Medical Marijuana, Namaste Technologies, Tetra Bio Pharma
Canamex obtains Bruner subsurface water right extension
CANAMEX GRANTED EXTENSION FOR SUBSURFACE WATER RIGHT FOR BRUNER GOLD PROJECT, NEVADA
Canamex Resources Corp. has provided the following update. The Nevada Division of Water Resources has granted Canamex Resources U.S. Inc. an extension through 2017 for a subsurface water right for the Bruner gold project located in Nye county, Nevada.
The water right application for beneficial use, submitted back in April, 2014, has been approved by the state engineer of Nevada, and Canamex Resources U.S. had been granted a water right for mining purposes for 0.78 cubic foot per second, or 350 gallons per minute, on the west side of the Bruner property in early 2015. This water right was due to expire if not perfected, and the company sought and was granted a one-year extension to perfect the water right. This right, when coupled with the 0.1 cubic foot per second (50 gallons per minute) that comes with the patented ground and the well location on the east side of the property, provides the company a total of 400 gallons per minute of beneficial use for mining purposes. This should be sufficient water for development of up to an 8,000-tonne-per-day initial heap-leach operation.
The company has to complete a well at the permitted location by Dec. 30, 2017, in order to perfect the water right, and then place the well into beneficial use by Dec. 30, 2018. The company plans to develop the water rights to be able to support the continuing exploration drilling effort in advance project development. The company has permitted a new well site with the BLM for the well that covers the existing water right, and will commence permitting of a well site that goes with the recently granted water right announced herein. The reclamation bond requirement for the new well site at the old water right is $1,400, and has to be posted before water well drilling begins. It is assumed the reclamation bond for the well site to perfect the new water right will be similar.
Statement by president Greg Hahn
“The issuance of sufficient water rights for an initial heap-leach operation at Bruner follows the company’s plan of anticipating development needs for the project and paralleling resource development and project development to facilitate moving the project forward expeditiously at the appropriate time,” stated Mr. Hahn, president and chief operating officer.
Mr. Hahn, a certified professional geologist, is the qualified person under National Instrument 43-101 responsible for preparing and reviewing the data contained in this press release.
We seek Safe Harbor.
© 2017 Canjex Publishing Ltd. All rights reserved.
- Published in Canamex Resources Corp., Mining, News Home
HealthSpace Welcomes Steven Lee to the Advisory Board and Grants Options
VANCOUVER, BC / TheNewswire / January 24, 2017 – HealthSpace Data Systems Ltd. (the “Company” or “HealthSpace”) is pleased to announce that Mr. Steven Lee has joined the Advisory Board of the Company.
Steven Lee :
Mr. Lee is a dynamic leader and experienced financial executive with a career focused on hypergrowth companies. As an early employee of Mobify, a privately-owned SaaS company with a staff size of 160, Mr. Lee successfully secured the company’s first financing (+$10M), led the M&A process of multiple US-based companies, oversaw a 300{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} growth in revenue and a 400{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} increase in staff with expansion into the UK and US, while providing strategic advice to the CEO and board of advisors. Mr. Lee was also an early employee of Slack Technologies, touted as the fastest company to reach a billion-dollar valuation. He was instrumental in creating infrastructure and helping to grow and scale the business through multiple rounds of financing and acquisitions.
Besides Mr. Lee’s expertise in SaaS, M&A and financing of high-growth companies, he also has many years of experience in senior management at Grant Thornton LLP. He is currently Chief Financial Officer for Rothbury Capital, a Canadian real estate investment company with strategic, income-producing investments in multiple US markets. Mr. Lee earned his Bachelor of Commerce from University of British Columbia and is a Chartered Professional Accountant (British Columbia).
The Company also announces that George Moen, who was recently appointed to the Company’s Advisory Board (see News Release dated January 11, 2017) has been appointed as Chair of the Advisory Board.
George Moen commented “I am very pleased to be appointed as Chairman of HealthSpace’s Advisory Board and we are thrilled to have Steven Lee join the team. Steven’s connections within the technology community and his experience in high-level M&A are anticipated to be of tremendous value to the Company. We plan on the addition of other high level talent to the Advisory Board in the coming year and look forward to helping the management team scale the business.”
The Company has granted 300,000 incentive stock options to Mr. Lee. Each stock option entitles Mr. Lee to purchase one common share of the company at a price of $0.08 per common share for a period of five years from the grant date.
About HealthSpace Data Systems Ltd.
HealthSpace is an industry leader providing inspection, information and communication management systems for federal, state, county and municipal governments. Over the last decade, the Company has successfully developed both enterprise and mobile internet-based applications currently serving over 300 state and local government organizations across North America. Clients range in size from small county organizations to state-wide systems with over 910 concurrent users, as well as national programs. HealthSpace specializes in the field of developing, installing, and maintaining inspection and regulatory management systems for environmental and public health organizations.
Forward-Looking Statements
This release may contain forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words “expects”, “plans”, “anticipates”, “believes”, “intends”, “estimates”, “projects”, “potential” and similar expressions, or that events or conditions “will”, “would”, “may”, “could” or “should” occur. Although HealthSpace believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results may differ materially from those in forward looking statements. HealthSpace expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.
For more information please contact:
Ali Hakimzadeh, Chairman
ali@sequoiapartners.ca
1-604-682-4600
Peter J. Kletas
PJK & Associates Inc.
1-866-999-6251
Copyright (c) 2017 TheNewswire – All rights reserved.
© 2017 Canjex Publishing Ltd. All rights reserved.
- Published in Health Space, News Home, Technology
Tetra BioPharma (TBP:CSE) Announces it Has Entered into a Clinical Research Partnership with Sante Cannabis, Quebec’s Leading Medical Cannabis Institution
Tetra BioPharma Announces it Has Entered into a Clinical Research Partnership with Sante Cannabis, Quebec’s Leading Medical Cannabis Institution
– Momentum Public Relations –
Press Release: January 23, 2017
PhytoPain Pharma Inc. (“PPP“), a subsidiary of Tetra Bio-Pharma Inc. (“TetraBio” or the “Company” or “TBP“) (CSE:TBP)(CSE:TBP.CN) is pleased to announce that it has entered into a clinical research partnership with Santé Cannabis. Under the partnership, Santé Cannabis will be working with PPP to develop the late phase clinical trial protocols that will be used to obtain substantial evidence of the safety and efficacy of PPP001 required for a new prescription drug approval from Health Canada and the USA Food and Drug Administration (“FDA“). These ground-breaking trials seek to receive the first approval for a Canadian-manufactured cannabis-based prescription medication.
Santé Cannabis is a private clinic specialized in the clinical application of medical cannabis for the treatment of pain and other chronic and terminal health conditions. The clinic’s team of physicians and support staff has unparalleled experience in the assessment and monitoring of medical cannabis patients. Santé Cannabis is the leading medical cannabis research institute in the province of Québec and the primary recruitment site for the province-wide Quebec Cannabis Registry. “Our clinic has provided services to almost 2,000 patients referred by over 1,500 physicians across Québec,” states Erin Prosk, Director of Santé Cannabis. “It is clear that both the medical community and the Quebec patient population are in desperate need of information about the potential benefits and risks of medical cannabis treatments. The status of medical cannabis as an unapproved treatment dissuades many physicians from writing a prescription and requires patients to pay for treatments out of pocket. Of the 2,000 patients that we have seen, there is not one who is not burdened by this financial barrier.”
Dr. Antonio A.L. Vigano, MD, MSc, will lead the Santé Cannabis team to administer the Phase II-III clinical trials in close collaboration with Dr. Irina Kudrina, MDCM, CCFP, CSP, and Santé Cannabis Medical Director Dr. Michael Dworkind, MD, CCFP, FCFP. Dr. Vigano is an attending physician in the Supportive and Palliative Care Service at the McGill University Health Centre and an Associate Professor in the McGill University Department of Oncology. He is the Director of the McGill Nutrition and Performance Laboratory and the Cancer Rehabilitation (CARE) Program. Dr. Vigano has assessed and followed approximately 400 patients during his 18-month tenure at Santé Cannabis. “It has become clear that medical cannabis can be a critical complementary therapy for the treatment of pain,” states Dr. Vigano. “Administering these late phase clinical trials is necessary to rigorously validate the efficacy and tolerability that I observe every day with my patients at Santé Cannabis. If specific medical cannabis products and protocols such as that we will design for PPP001 can withstand the pharmaceutical approval process, it cannot be denied as a valid pain therapy. Cost-coverage should be a logical next step.”
Dr. Irina Kudrina is a McGill-certified pain physician and an attending physician and head of the chronic pain services at the Queen Elizabeth GMF-U and Assistant professor and clinician-researcher at the McGill University Department of Family Medicine. “At present, medical cannabis has already become an important medicine in the fields of oncology, chronic pain, neurology and others. In a clinical review* published in Journal of the American Medical Association (2015), Harvard-based researchers highlighted its use in some medical conditions as being supported by high quality evidence. In Canada, the efforts by regulatory, medical, and pharmaceutical bodies and by the patient advocacy movements have been targeting multiple structural, legal and information barriers still prevailing from the times when long-term high dose opioid therapy was prescribed to chronic pain patients despite its chronic toxicity effects and without high quality evidence for such use. While the clinical use of medical cannabis remains a stigmatized and poorly researched option for some medical conditions, sufficiently large-scale late-phase clinical trials on efficacy, safety and tolerability of medical cannabis are long overdue. These studies might open the door for another class of medications in an attempt to fill the current significant gap for more long-term pharmacological options.”
*(https://www.ncbi.nlm.nih.gov/pubmed/26103031)
PPP entered into this partnership because of Santé Cannabis’ unique expertise and dedication to a pharmacovigilance approach in medicine. The clinic has established clinical practices that help minimize adverse effects in patients and will help design the treatment protocols for the Phase II-III studies. According to Dr. Guy Chamberland, Chief Scientific Officer and Regulatory Affairs, “Adequately designing a late phase clinical trial for the evaluation of the safety and efficacy of inhaled Cannabis requires clinical teams experienced in handling the administration of Cannabis by inhalation to patients. The medical experts of Santé Cannabis complement the scientific and medical experts of our Clinical Advisory Board and provide PPP with an exceptionally solid foundation for the clinical development of Cannabis products as prescription drugs.”
Once authorized by Health Canada, Santé Cannabis will be recruiting participating physicians and patients from the Montreal area throughout 2017. For more information, please contact the clinic by email at info@santecannabis.ca.
About Santé Cannabis:
Santé Cannabis is Québec’s only medical clinic and resource centre dedicated to the clinical practice and research of medical cannabis treatments. Since opening in November of 2014, physicians at Santé Cannabis have assessed almost 2,000 patients referred by more than 1,500 physicians across the province of Québec. Santé Cannabis currently administers several clinical study protocols, including the Québec Cannabis Registry in collaboration with the Research Institute of the McGill University Health Centre and in accordance with the regulations of the Collège des Médecins du Québec.
- Published in Life Sciences, Medical Marijuana, News Home, Tetra Bio Pharma
Deep-South (DSM:tsxv) appoints Leveille as CEO, Stuart-Willams as Vice-President Exploration and hires Paradox for Investor Relation
Deep-South appoints Leveille as CEO, Stuart-Willams as Vice-President Exploration and hires Paradox for Investor Relation
– Momentum Public Relations –
Press Release: January 23, 2017
Deep-South Resources inc. (DSM:tsxv) announces that it has appointed Pierre Léveillé as CEO and Vivian Stuart-Williams as Vice-President Exploration. Tim Fernback has resigned as CEO but will remain as Vice-President and Director of the Board of Directors.
Mr. Léveillé has over 28 years of experience in the International financial sector including 20 years in the mining exploration industry. Mr. Léveillé has started is career as a Stock Broker and Corporate Finance advisor with a National brokerage firm. From the mid 1990’s to today, he has been Executive and Director of exploration companies active in Africa. He has financed and managed exploration projects in Namibia since 1996. Mr. Léveillé is President of Q7 Capital inc., a private company providing financial and management advisory services to public and private companies.
Mr. Stuart-Williams is a geologist with 46 years of experience in the mining and exploration industry, principally in the southern African region. He holds a M.Sc degree in uranium and he has been involved in base metals, gold, coal, and industrial mineral projects. Mr. Stuart-Williams has a worldwide exposure (including Liberia, Philippines, Afghanistan, Canada, Uzbekistan, Australia, Uganda, Mauritania and all of the Southern African countries). He has been involved with the Haib project from the mid-1990s as exploration Manager and subsequently as a Technical Director (geology) for Deep South Mining who held the Mineral Rights over the Haib Project during the recent exploration by Teck Namibia.
Mr. Tim Fernback has resigned has CEO but will remain Vice-President and Director.
The Board of Directly is highly pleased with those nominations as they will bring a wealth of experience and knowledge and will add value to the current team in place. The Board also acknowledge the work of Mr. Fernback during the company’s conversion and is pleased with his commitment and that he stays involved with the company.
Deep-South also announces that it has hired Paradox Public Relations Inc. to provide investor relations services. Paradox will focus on the development and expansion of the company’s communications with the investment community through a comprehensive investor relations program. Under the terms of the agreement, Deep-South will pay Paradox $5,000 per month for a term of 24 months and may be cancelled by either party by giving 30 days notice. The company will grant Paradox incentive options to acquire 350,000 common shares in the share capital of the company at a price of $ 0.25 per share for a period of two years, vesting quarterly over 12 months.
About Deep-Sout Resources Inc.
Deep-South Resources Inc. is a Canadian company, actively involved in the acquisition, exploration and development of major mineral properties in Namibia and Canada. Deep-South growth strategy is to focus on the exploration and development of quality assets, in significant mineralized trends, close to infrastructure, in stable countries.
- Published in Deep South Resources Inc., Mining, News Home
These are the African countries investors should pay attention to
About half of all the African countries either host significant operating mines or have advanced exploration projects, yet investors tend to shy away due to perceived risks such as high levels of corruption and political uncertainty, a new report shows.
There are many rankings that aim to help companies choose the best countries to set up shop in the region, such as Canada’s Fraser Institute annual report and Transparency International’s corruption index, but London-based finnCap has come up with one of its own.
The investment bank analyzed the 25 (roughly) countries in Africa that have working mines or or advanced exploration projects, incorporating the best known rankings available, but factoring each country’s geological potential and their current security risk.
So, what did they conclude?
The first and main finding is that there is an urgent need to refill the mining project pipeline of all African countries with early stage exploration projects of all shapes and sizes.
But where to start? According to finnCap, investors would be better off in Ghana, Botswana, Namibia, Lesotho and Senegal, which already have companies successfully operating inside their borders. These include, just to name a few, Kennedy Ventures (Tantalite Valley tantalum mine) and Weatherley (Tschudi copper mine) in Namibia, as well as Firestone Diamonds (Liqhobong diamond mine) and Gem Diamonds (Lesteng diamond mine) in Lesotho.
At the bottom of the bank’s list figure Eritrea, Kenya, Zimbabwe, Guinea and Angola, which also have a few known names present in their mining sector. Those include Avocet (Tri-K gold project) in Guinea, ASA Resource Group (Freda Rebecca gold mine and Bindura nickel mine) and Caledonian (Blanket gold mine) in Zimbabwe, and Base Resources (Kwale mineral sands mine in Kenya.
“There is a lot of money to be made if country risk and entry timing can correctly be judged,” the reports says, citing as an example Randgold Resources’ success story in Mali, which started off with a small gold mine back in 1995 when the country had had no mining industry other than some artisanal operations.
Within five years, Randgold’s Morila gold mine (jointly owned and managed with AngloGold) had become one of the world’s more profitable mines and laid the foundations for the growth of the business.
So the lesson for investors should be to always look at the risk/reward balance, the analysts say. Does outstanding geology beat corruption and security issues, including but not limited to the threat of the radical Muslim insurgencies? This mostly comes down to the quality of company management and their in-country experience, they conclude.
Source (Mining.com)
- Published in Blog, Deep South Resources Inc., Mining
Cobalt Crunch Time
Cobalt Crunch Time
Source – Rockstone Research
http://www.rockstone-research.com/images/PDF/KingsBay2en.pdf
Apparently, there is no shortage of lithium development projects worldwide, but there is a shortage of lithium processing capacities.
In case of the other battery-critical element, cobalt, there is a shortage of development projects especially in safe jurisdictions. Some 65{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} of global cobalt production comes from the “Democratic Republic” of the Congo, an extremely political unstable country with deeply-rooted corruption, where approximately 20{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} of the nation’s cobalt output originates from unregulated, illegal artisanal miners, of which an estimated 40,000 miners are children according to UNICEF. James West recently explained:
“Auto makers need cobalt that is not mined artisanally because the supply chain gets audited. So the hot commodity is to find non-Congolese cobalt sulphate and nickel sulphate.”
Andrew Miller from Benchmark said:
“In many ways, the cobalt industry has the most fragile supply structure of all battery raw materials.”
In 2014, Tesla pledged to use only North American resources for its battery production at its Gigafactory and has also claimed to stop sourcing its cobalt from the Philippines due to environmental concerns, which will be a future issue for cobalt as demand rises.
The cobalt market has been gaining momentum both in price and global awareness about the precariously escalating supply-demand metrics. Cobalt is about to become the next “big thing”, a hype that has unique fundamental ingredients to outshine the lithium boom. MetalBulletin recently noted:
“Cobalt prices continued to surge this week as stocks remained in tight hands amid anticipations of further investor-fuelled price rises.”
No wonder that Tesla’s big kahuna, Elon Musk, has started to knock on cobalt doors in the Western World to offer offtake agreements. However, cobalt developers are in a much stronger negotiating position than mighty Musk has previously thought. This is somewhat in stark contrast to the lithium space and shows quite plainly that the cobalt boom will be different from lithium. It will be pivotal, for Tesla and all the others trying to jump on the bandwagon of global electrification. No cobalt, no Tesla?
The current battery of a Tesla Model S includes about 23 kg of cobalt, that´s up to 60{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} cobalt by weight. Already today, battery usage accounts for almost half of total cobalt demand. By 2020, cobalt use in battery applications alone is expected to be greater than the entire world market for refined cobalt in 2015. About 97{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} of global cobalt supply comes as a by-product. According to CRU, 60{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} of current cobalt production comes from copper mining, 38{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} from nickel operations and only 2{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} from primary cobalt mines in Morocco and Uganda. Last year, Freeport McMoRan and Lundin sold its stakes in the Tenke Fungurume Mine in Congo, one of the world´s largest known cobalt deposits, to China Molybdenum.
James West recently spoke to Robert Friedland from Ivanhoe Mines Ltd., who had the following story to share:
“Elon came to me because we have a nickel sulphate and cobalt sulphate operation in Australia, not the Congo,” he said. “And Elon said ‘I’ve got the world’s biggest battery factory, so I want to buy your nickel and your cobalt at the current metal price for 10 years, because I’m the biggest buyer.’ “
So we told Elon Musk, you know, Elon, that’s interesting. We’ll think about it. And then two months later we went back to him and said “Elon, you’re totally screwed. The Germans are building a gigafactory twice as big as yours, the Chinese are building four of them bigger than yours, the Japanese are building two and the Koreans are building one. So unless you’re willing to pay to buy our cobalt and our nickel at whatever the price may be in the future, you’re not going to be able to build any batteries in your own gigafactory and your whole company is going out of business, and we’re going to make money shorting your stock.”
Surface sampling on the Lynx Lake Property returned high grades of cobalt and copper.
Looking at cobalt projects around the world and particularly in North America, Rockstone has found the Lynx Lake Copper-Cobalt Project from King’s Bay Gold Corp. being one of the best early-stage projects, with a real chance of making a significant discovery with a drill program. Generally, cobalt grades of 0.5{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} are considered world-class.
Although surface grades are not comparable to resources, reserves or production grades, King’s Bay’s grab samples of 0.94{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} cobalt, 1.39{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} copper, 0.21{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} nickel, 0.23{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} vanadium, 0.39{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} molybdenum, 0.0112{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} bismuth and 6.5 g/t silver are an indication of what the upcoming drill program may discover.
Above map shows the The Lynx Lake Property before it was expanded from 20 to 240 km2. The property benefits from proximity to the Trans-Labrador Highway (to the left of below picture) and a 3-phase power line running across the property (to the right of below pricture). The Trans-Labrador Highway goes directly to deep water ports.
With so much interest being garnered in the cobalt sector the company has been feverishly working to advance its Lynx Lake Copper-Cobalt Property in Labrador. Below is a list of milestones that King’s Bay has completed in the first 20 days of 2017.
On January 3, the company closed a financing with total proceeds of $938,753 CAD.
On January 11, the permit for an airborne electromagnetic (“EM”) geophysics survey was received.
On January 17, the company increased the Lynx Lake Copper-Cobalt Property land package from 20 to 240 km2 in order to adequately cover the geological structures and geophysical signatures of interest.
On January 19, the closing of the Lynx Lake Property acquisition was announced.
The next steps for King’s Bay will be the completion the airborne survey and evaluation of the data for high priority drilling targets in the spring. The company will be looking to expand its holdings in the cobalt sector through potential acquistions and or joint ventures.
Historical Timeline Lynx Lake Copper-Cobalt Property
This survey will be strategically placed within the newly expanded land area in order to explain some of the EM anomalies that have been discovered during surficial reconnaissance. Government regional low resolution residual magnetic surveys and preliminary handheld electromagnetic surveys done by local prospectors have shown strong conductors beneath the overburden, and provide incentive to explore the area further for additional subsurface mineralization.
Prior to 2008, the property was deemed too remote and as such remained virtually unexplored. In 2008, the Department of Transportation constructed the new Trans-Labrador Highway, which now runs through the property, making it easily accessible. During blasting for road aggregate on the property in the same year, disseminated and massive sulphide mineralization was discovered.
In 2009, local prospectors sampled and assayed the aggregate quarry on the eastern portion of the property and assayed up to 0.94{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} cobalt, 1.39{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} copper, 0.21{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} nickel and 6.5 g/t silver.
In 2014, regional low resolution magnetic surveys by the government and hand-held electromagnetic surveys by local prospectors revealed strong conductors beneath the overburden.
In 2015, the western portion of the property was grab sampled, yielding 0.57{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} cobalt, 1.03{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} copper, 0.1{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} nickel, 0.36{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} chromium, 0.39{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} molybdenum, 0.23{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} vanadium and 5 g/t silver.
Discovery Potential
Although the property has never been drilled before, the sampling assays in both the eastern and western part of the property (before it was expanded) indicate great possibility for a large body of mineralization at shallow depths. Thanks to excellent road accessibility to deep sea water ports, a power line that runs directly adjacent to the property and the proximity to the town of Happy Valley-Goose Bay, King’s Bay believes that it’s a perfect time now to explore this highly prospective property amid rising energy metal prices, first and foremost the battery-critical element cobalt.
King´s Bay will be exhibiting at the upcoming Vancouver Resource Investment Conference(booth #301) this Sunday and Monday as well as the AME Round Up which runs from January 30 to February 2 (booth #424). The Government of Newfoundland & Labrador has provided King´s Bay with an opportunity to participate within their booth. CEO Kevin Bottomley and Director Brad Hoeppner will be travelling to St. John´s for the Northern Exposure Conference (booth #201) which runs from January 24 to 26.
Rockstone is looking forward to King’s Bay’s upcoming geophysics and subsequent drill program as a massive cobalt-rich deposit may get discovered.
Previous Coverage
Report #1: “Potential for a Massive Discovery of Cobalt, Copper and High-Tech Metals” (October 27, 2016)
Company Details
King‘s Bay Gold Corp.
Suite 1450 – 789 West Pender Street
Vancouver, B.C. V6C 1H2 Canada
Phone: +1 604 681 1568
Email: brad@kingsbayres.com
www.kingsbayres.com
Shares Issued & Outstanding: 40,806,423
Canadian Symbol (TSX.V): KBG
Current Price: $0.11 CAD (01/19/2017)
Market Capitalization: $5 million CAD
German Symbol / WKN (Frankfurt): KGB1 / A2AN0E
Current Price: €0.073 EUR (01/19/2017)
Market Capitalization: €3 million EUR
Disclaimer: Please read the full disclaimer within the full research report as a PDF (here) as fundamental risks and conflicts of interest exist.
- Published in Blog, King's Bay, Mining
Support the Troops: Invest in Legal Cannabis!
How to Make Money and Save Lives at the Same Time
It’s not just about the money.
I know, this is not typically something you’d expect to read from an investment analyst, so let me explain …
A few years ago, I started writing about investment opportunities in the legal cannabis space. As a result, I was accused by many of compromising my ethics in an attempt to make a quick buck. But nothing could be further from the truth.
Yes, one of the reasons I invest in the cannabis space is because it’s insanely profitable. And I make no apologies for this, nor should any other right-minded capitalist who enjoys the spoils of free markets and the good fortune to create wealth and prosperity.
The truth is, at the moment, there is no greater investment opportunity than legal cannabis. And I have dozens of double- and triple-digit winners in my portfolio to back up this claim. Some of my most profitable cannabis investments right now include a 501{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} gain on Canopy Growth Corporation (TSX: CGC), a 373{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} gain on Aphria, Inc. (TSX-V: APH), and a 567{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} gain on OrganiGram (TSX-V: OGI). And there are plenty more to come, too.
But while few things make me smile more than watching my brokerage account grow, this is not the onlyreason to invest in the legal cannabis market.
Three Reasons to Invest in Legal Cannabis
Aside from the massive profit potential, there are three other reasons you should be investing in legal cannabis right now:
- Legalization helps slow the war on drugs, which has been one of the most violent and costliest wars in recorded history. More than $1 trillion has already been spent on this war, and it’s put millions of folks — particularly the poor — in early graves.
- Legalization helps build local economies, which, in this day and age, is something we need to embrace, not shun.
- Legalization on the medical side allows millions of Americans to treat illness when other “legal” pharmaceuticals have failed. How anyone could look at a young child with severe epilepsy and deny that child a medical cannabis therapy that’s proved to work is beyond me.
Of course, it’s not just kids with epilepsy that have benefited from cannabis.
Support the Troops
Last year, while attending a legal cannabis conference in New York City, I met a man named Sean Kiernan.
Kiernan is the co-founder of a group called Weed for Warriors. It’s an advocacy group that works to provide access to medical cannabis for military veterans suffering from PTSD.
Now, the fact that a military veteran — someone who has risked his or her life for this country — can be denied medicine to treat PTSD is despicable. Especially when you look at some pretty unsettling statistics.
The suicide rate for veterans is extremely high. Every year, about 8,000 veterans commit suicide. That means that since we first invaded Iraq back in 1991, more than 200,000 U.S. veterans have taken their own lives. And understand, this is a group that makes up just 7{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} of the U.S. population but represents 20{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} of the national suicide rate. And that’s assuming these numbers are accurate — which they are not.
Truth is, this data has only been collected from 21 states and only accounts for the vets who have been seen by the Veterans Affairs Administration. Sadly, those numbers are likely considerably higher. And that’s an absolute travesty. Especially when you consider that many of these deaths could’ve been avoided.
You see, there’s a significant amount of evidence that indicates cannabis can effectively treat the symptoms of PTSD. One study in particular, conducted by the scientific journal Drug Testing and Analysis found that cannabis could “dampen the strength or emotional impact of traumatic memories through synergistic mechanisms that might make it easier for people with PTSD to rest or sleep and to feel less anxious and less involved with flashback memories.”
Of course, to get similar conclusions, one could also simply ask any veteran who uses cannabis to treat the effects of PTSD.
Some do it legally, assuming they live in states where cannabis has been legalized for the treatment of PTSD, and some do it illegally, since the very country that sent them off to war won’t allow them to medicate as they see fit.
Think about that for a moment.
These folks put their lives on the line for us every single day. They’re not paid large sums of money to do this either. These are honorable men and women who not only deserve to be treated with the respect they’ve earned, but also deserve the right to use any medication they choose to keep them safe and healthy.
How any lawmaker in this country could deny a United States veteran medication is beyond me. As far as I’m concerned, this is nothing short of a human rights violation.
Regular People have the Power to do Great Things
Most of us are just regular people.
We’re not billionaires with loads of influence in Washington. We’re not lawmakers, judges, or high-profile celebrities. But that doesn’t mean we can’t do our part to keep our vets healthy and safe.
You see, as investors, collectively, we have an enormous amount of power. Every day, billions of dollars worth of public equities are bought and sold on the open market. And I’m not talking about fancy algorithms created by investment banks and hedge funds. I’m talking about regular, retail investors. Folks that have online trading accounts and are happy with year-end returns of eight to ten percent.
Now imagine if all these investors decided to allocate just one percent of their portfolios to stocks that represent companies that are making it possible for our veterans to get the relief many of them need by providing medical-grade cannabis.
While the U.S. government may not be willing to do right by the very people that protect our democracy, we can override that decision through our collective purchasing power, which will result in strengthening the cannabis industry thereby making it harder and harder for the government to continue its prohibition against something that, quite frankly, never should’ve been prohibited in the first place.
Of course, I’m not suggesting you run out and buy a bunch of random cannabis stocks. Especially those listed in the U.S., which, for the most part, are garbage. Investing in a stock that’s not going to make you any money makes no sense. Particularly because such a stock is likely issued by a company that’s not going to be around very long. And that’s not going to help anyone.
But there are exceptions. Take Innovative Industrial Properties (NYSE: IIPR) for instance. This is a REIT that acquires specialized industrial real estate assets that are used for growing medical-use cannabis and operated by state-licensed growers. Just a few weeks ago, IIPR closed its first transaction with PharmaCann, a cultivator of medical-grade cannabis. This transaction alone guarantees the company an initial base rent of $319,580 per month. That ain’t chump change.
It should also be noted that the company’s executive chairman is the guy who co-founded BioMed Realty Trust, which was sold to Blackstone last year for $8 billion. These guys aren’t amateurs.
Of course, if you’d rather focus on actual cannabis producers, one of your best bets might be with Emblem Corp. (TSX-V: EMC).
While this is a Canadian cannabis producer, management is actively developing advanced cannabis formulations designed to help folks with PTSD. This research alone could prove to be incredibly valuable to other producers in the U.S. that are currently providing cannabis for vets with PTSD.
Here’s the bottom line: As a legal cannabis investor, we can not only make a lot of money, but we can also help facilitate a movement that can help our veterans get the medication they need… a medication that could help these folks live normal lives… a medication that could quite possibly decrease the number of veterans that commit suicide, too.
And that, my friend, is an honorable investment.
Source (Wealth Daily)
- Published in Blog, Medical Marijuana, Namaste Technologies, Tetra Bio Pharma
Natan Resources (NRL:tsxv) Announce Channel Samples Assay up to 438.23 gpt Gold
Montalembert: Channel Samples Assay up to 438.23 gpt Gold
– Momentum Public Relations –
Press Release: January 20, 2017
ROUYN-NORANDA, QUÉBEC–(Marketwired – Jan. 20, 2017) -NATAN RESOURCES LTD (TSX VENTURE:NRL)(FRANKFURT:N071) and GLOBEX MINING ENTERPRISES INC.(TSX:GMX)(FRANKFURT:G1M)(STUTTGART:G1M)(BERLIN:G1M)(MUNICH:G1M)(XETRA:G1M)(OTCQX:GLBXF) are pleased to provide shareholders with an update as regards channel sampling undertaken on the Montalembert Gold Property located near Waswanipi, Quebec.
In October 2016, a total of 208 channel samples were collected ranging from 0.5 m to 1.35 m in length, averaging 0.97 metre.
- 122 samples were taken in 25 channel lines on the Number 2 vein system with channels being spaced 3 metres apart;
- 64 samples were taken in 16 channel lines on the Galena vein system with channels being spaced 10 metres apart;
- 11 samples were taken on a stripped area between the Number 2 vein system and the Galena vein system as were 11 samples on a similar stripped area 60 m to the south.
The mineralization on the Montalembert gold property consists of coarse free gold in or near quartz vein systems. The veins were stripped and power washed to facilitate detailed mapping and subsequent channel sampling. Channel sampling of free gold occurrences is a hit or miss process due to the erratic distribution of coarse free gold in quartz vein systems.
Numerous anomalous gold values were received from the vein systems with the best assays listed below.
Vein System # 2
Four out of five channel samples over a 12 m strike length assayed as follows:
Sample # | Au gpt | Ag gpt | Width |
D109955 | 8.88 | 2.6 | 0.75 |
D109952 | 39.35 | 14.4 | 1.10 |
D109580 | 5.07 | July 2016 channel not analysed for silver | 0.95 |
D109891 | 4.56 | 1.8 | 0.9 |
Previous grab samples in the area assayed 84.04 gpt Au (ID# D107317), 36.26 gpt Au (ID# D107315) and 17.26 gpt Au (ID# D107311).
Grab sample, ID# D107447, taken 27 m north of the grouping of gold values reported above, assayed 64.48 gpt Au. Of the Vein #2 channel samples, 16.3{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} returned assays over 0.1 gpt Au.
Galena Vein System
The Galena Vein is where historical trenching over a near continuous strike of 123 m, an average width of 0.65 m and an average depth of 0.6 m in 78 samples weighing approximately 3.6 kg each averaged 20.8 gpt Au(28.9 gpt Au uncut) were reported by Rochelom Mines Ltd. in 1974.
A channel sample, ID# 110059, taken where Globex grab samples previously showed coarse visible gold, assayed 119.94 gpt Au and 14.5 gpt Ag over a width of 1 m. With the two adjoining samples, the three continuous samples averaged assayed 40.32 gpt Au and 5.02 gpt Ag over 3 m.
A channel sample, ID# D110069, taken 18 m to the south of the 40.32 gpt Au over 3 m contained coarse visible gold and assayed 438.23 gpt Au and 145.2 gpt Ag over 1 m, the highest single assay in the current sampling program.
Two consecutive channel samples, ID# D110102 and D110103, taken 62 m further to the south averaged 4.64 gpt Au over 1.65 m. Near the south end of the Galena stripping, channel sample, ID# D110122, assayed 1.58 gpt Au over 0.9 m. The Galena vein has a high gold background with 40.6{92d3d6fd85a76c012ea375328005e518e768e12ace6b1722b71965c2a02ea7ce} of the samples averaging over 0.1 gpt Au.
Other
No high grade gold assays were reported from the two stripped areas that cover a portion of the ground between the two gold bearing vein systems. Only a portion of the exposed rock was channel sampled.
Conclusion
Considering the erratic distribution of the coarse gold mineralization observed on surface, the channel sampling succeeded in confirming a significant set of gold bearing vein systems (Galena and Number 2). Typically in such vein systems, the preferred and more definitive manner to define the average gold grade and the economic potential is to do a bulk sample which would provide a large enough volume to more closely reflect the grade and potential of the vein systems.
Natan is studying the channel results along with the recent grab sampling, historical trenching, detail mapping and geophysical surveys in order to design the next phase of exploration. Natan is well financed recently having raised $4 million.
The channel samples were assayed at Laboratoire Expert in Rouyn-Noranda, Quebec using standard fire assay methods. A strict quality assurance/quality control program was applied to all samples, which includes insertion of mineralized reference materials or blank samples or duplicates for each batch of 20 samples. The gold analyses were completed by fire assay with an atomic absorption finish on 30 grams of materials. Repeats were carried out by fire assay followed by gravimetric testing on each sample containing one gpt gold or more.
Note: Grab samples are selective by nature and are unlikely to represent average grades. Channel samples, on the other hand, are not selective by nature, the same as drill holes are not selective.
The Montalembert property was optioned to Natan by Globex. (See Natan and Globex press releases dated November 17, 2016 for details)
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of the release.
This press release was written by Jack Stoch, P. Geo., President and CEO of Globex in his capacity as a Qualified Person (Q.P.) under NI 43-101.
We Seek Safe Harbour.
Forward Looking Statements: Except for historical information, this news release may contain certain “forward looking statements”. These statements may involve a number of known and unknown risks and uncertainties and other factors that may cause the actual results, level of activity and performance to be materially different from the expectations and projections of Natan Resources Ltd (Natan) and Globex Mining Enterprises Inc. (“Globex”). No assurance can be given that any events anticipated by the forward-looking information will transpire or occur, or if any of them do so, what benefits Globex and Natan will derive therefrom. A more detailed discussion of the risks is available in the “Annual Information Form” filed by Globex on SEDAR at www.sedar.com
Jack Stoch, P.Geo., Acc.Dir.
President & CEO
Globex Mining Enterprises Inc.
info@globexmining.com
Steve Roebuck,P.Geo
President & CEO
Natan Resources Ltd
info@natanresources.ca
- Published in Enforcer Gold Corp, Mining, News Home